Francisco Vega

Professor of Clinical

  • 3565 Citations
19962019
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research interests

  • socio-cultural issues in music education

Fingerprint Dive into the research topics where Francisco Vega is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 21 Similar Profiles
Lymphoma Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
B-Lymphocytes Medicine & Life Sciences
T-Cell Lymphoma Medicine & Life Sciences
B-Cell Lymphoma Medicine & Life Sciences
Follicular Lymphoma Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

CRISPR genome editing of murine hematopoietic stem cells to create Npm1-Alk causes ALK1 lymphoma after transplantation

Rajan, S. S., Li, L., Kweh, M. F., Kunkalla, K., Amin, A. D., Agarwal, N. K., Vega, F. & Schatz, J. H., Jan 1 2019, In : Blood Advances. 3, 12, p. 1788-1794 7 p.

Research output: Contribution to journalReview article

Open Access
Clustered Regularly Interspaced Short Palindromic Repeats
Hematopoietic Stem Cells
Lymphoma
Transplantation
Gene Editing

Disseminated cutaneous immunoglobulin M macroglobulinosis associated with cryoglobulinemia and minimal residual disease of Waldenström macroglobulinemia

Fayne, R., Rosenberg, M., White, K., Alencar, A., Kirsner, R. S., Vega, F. & Cho-Vega, J. H., Oct 2019, In : JAAD Case Reports. 5, 10, p. 918-922 5 p.

Research output: Contribution to journalArticle

Open Access
Waldenstrom Macroglobulinemia
Cryoglobulinemia
Residual Neoplasm
Immunoglobulin M
Skin

Erratum: CARM1 Is Essential for Myeloid Leukemogenesis but Dispensable for Normal Hematopoiesis (Cancer Cell (2018) 33(6) (1111–1127.e5), (S1535610818302216), (10.1016/j.ccell.2018.05.007))

Greenblatt, S. M., Man, N., Hamard, P. J., Asai, T., Karl, D., Martinez, C., Bilbao, D., Stathias, V., Jermakowicz, A. M., Duffort, S., Tadi, M., Blumenthal, E., Newman, S., Vu, L., Xu, Y., Liu, F., Schurer, S. C., McCabe, M. T., Kruger, R. G., Xu, M. & 5 others, Yang, F. C., Tenen, D. G., Watts, J., Vega, F. & Nimer, S. D., Jan 14 2019, In : Cancer Cell. 35, 1, 1 p.

Research output: Contribution to journalComment/debate

Hematopoiesis
Names
Neoplasms
coactivator-associated arginine methyltransferase 1
1 Citation (Scopus)

LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCL

Parvin, S., Ramirez-Labrada, A., Aumann, S., Lu, X. Q., Weich, N., Santiago, G., Cortizas, E. M., Sharabi, E., Zhang, Y., Sanchez-Garcia, I., Gentles, A. J., Roberts, E., Bilbao-Cortes, D., Vega, F., Chapman, J. R., Verdun, R. E. & Lossos, I. S., Sep 16 2019, In : Cancer Cell. 36, 3, p. 237-249.e6

Research output: Contribution to journalArticle

Poly(ADP-ribose) Polymerases
Lymphoma, Large B-Cell, Diffuse
T-Cell Lymphoma
Homologous Recombination
Precursor Cell Lymphoblastic Leukemia-Lymphoma